Combined therapy with Luteinizing Hormone Releasing Hormone agonist (LHRHa) and Growth Hormone (GH) in central precocious puberty

Acta Biomedica de l'Ateneo Parmense

Volumn 76, Issue 2, 2005, Pages

  Volta, Cecilia ^a   Regazzi, Carla ^a   Ndaka, Juliette ^a   Vitale, Rosa ^a   Bernasconi, Sergio ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Central precocious puberty; Growth hormone; LHRH analogues

Indexed keywords

GONADORELIN; GONADORELIN DERIVATIVE; GROWTH HORMONE; TRIPTORELIN;

BODY GROWTH; BODY HEIGHT; CENTRAL PRECOCIOUS PUBERTY; CHILD; CLINICAL TRIAL; DEPRESSION; DRUG CHOICE; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; FEMALE; GROWTH RATE; HOT FLUSH; HUMAN; MALE; MENOPAUSAL SYNDROME; META ANALYSIS; NAUSEA; OSTEOPOROSIS; PRECOCIOUS PUBERTY; PREDICTION; REVIEW; SYSTEMATIC REVIEW; WITHDRAWAL BLEEDING;

DRUG THERAPY, COMBINATION; FEMALE; GONADOTROPIN-RELEASING HORMONE; GROWTH HORMONE; HUMANS; MALE; PUBERTY, PRECOCIOUS;

EID: 31944433303     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Partsh CJ, Hager S, Sippel WG. Management and outcome of central precocious puberty. Clin Endocrinol 2002; 56: 129-48.
2. Kelnar JH, Stanhope R. Height prognosis in girls with central precocious puberty treated with GnRH analogues. Clin Endocrinol 2002; 56: 295-6.
3. Volta C, Bernasconi S, Cisternino M, et al. Isolated premature thelarche and thelarche variant: clinical and auxological follow-up of 119 girls. J Endocrinol Invest 1998; 21: 180-3.
4. Ehrhardt AA, Meyer-Bahlburg HFL. Idiopathic precocious puberty in girls: long-term effects on adolescent behaviour. Acta Endocrinol 1986; 279 (Suppl): 247-53.
5. Kauli R, Galatzer A, Kornreich L, Lazar R, Pertzelan A, Laron Z. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method. Horm Res 1997; 47: 54-61.
6. Klein KO, Barnes K, Jones JV, Feuillan PP, Cutler GB. Increased final height in precocious puberty after long-term treatment with LHRH analogues: the National Institutes of Health Experience. J Clin Endocrinol Metab 2001; 86: 4711-6.
7. Antoniazzi F, Bertoldo F, Lauriola S, et al. Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment. J Clin Endocrinol Metab 1999; 84: 1992-6.
8. Walvoord EC, Pescovitz OH. Combined use of growth hormone and gonadotropin releasing hormone analogues in precocious puberty: theoretic and practical considerations. Pediatrics 1999; 104: 1010-4.
9. OOstdijk W, Drop SLS, Odink RJH, Hummelink R, Partsch CJ, Sippel WG. Long-term results with a slow-release gonadotropin-releasing hormone agonist in central precocious puberty. Acta Paediatr Scand (Suppl) 1991; 372: 39-45.
10. Saggese G, Pasquino AM, Bertelloni S, et al. Effect of combined treatment with gonadotropin releasing analogue and growth hormone in patients with precocious puberty who had subnormal growth velocity and impaired height prognosis. Acta Paediatr 1995; 84: 299-304.
11. Tato L, Saggese G, Cavallo L, et al. Use of combined Gn-RH agonist and hGH therapy for better attaining the goals in precocious puberty treatment. Horm Res 1995; 44 (Suppl 3): 49-54.
12. Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerrone F. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone. J Clin Endocrinol Metab 1999; 84: 449-52.
13. Pucarelli I, Segni M, Ortore M, Arcadi E, Pasquino AM. Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution. J Pediatr Endocrinol Metab 2003; 16: 1005-10.
14. Hileman SM, Pierroz DD, Flier JS. Leptin, nutrition, and reproduction: timing is everything. J Clin Endocrinol Metab 2000; 85: 804-7.
15. Virdis R, Street ME, Zampolli M, et al. Precocious puberty in girls adopted from developing countries. Arch Disease in Childhood 1998; 78: 152-4.
16. Tuvemo T, Gustafsson J, Proos LA and the Swedish growth Hormone Advisory Group. Growth hormone treatment during suppression of early puberty in adopted girls. Acta Paediatr 1999; 88: 929-32.
17. Mul D, Oostdijk W, Waelkens JJJ, Schulpen TWJ, Drop SLS. Gonadotropin releasing hormone agonist treatment with or without recombinant human GH in adopted children with early puberty. Clin Endocrinol 2001; 55: 121-9.
18. Lee PA. The effects of manipulation of puberty on growth. Horm Res 2003; 60 (Suppl 1): 60-7.
19. Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Antoniazzi F. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. J Endocrinol 1999; 141: 140-4.
20. Mul D, Oostdijk W, Otten BJ, et al: Final height after gonadotropin-releasing hormone agonist treatment for central precocious puberty. J Pediatr Endocrinol Metab 2000; 13: 765-72.
21. Heger S, Partsch C, Sippell WG. Long term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportion, bone mineral density, and reproductive function. J Clin Endocrinol Metab 1999; 84: 4583-90.
22. Galluzzi F, Salti R, Bindi G, Pasquini E, La Cauza C. Adult height comparison between boys and girls with precocious puberty after long-term gonadotropin-releasing hormone analogue therapy. Acta Paediatr 1998; 87: 521-7.